Yeru Tan

498 total citations · 1 hit paper
26 papers, 362 citations indexed

About

Yeru Tan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yeru Tan has authored 26 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yeru Tan's work include Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (7 papers). Yeru Tan is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (7 papers). Yeru Tan collaborates with scholars based in China and Singapore. Yeru Tan's co-authors include Hongbo Zhu, Yuehua Li, Xiaoping Wu, Yuehua Li, Rongfang He, Yiling Jiang, Jingping Yuan, Xiaofei Qu, Hailin Tang and Jindong Xie and has published in prestigious journals such as Scientific Reports, Current Opinion in Cell Biology and Frontiers in Immunology.

In The Last Decade

Yeru Tan

24 papers receiving 360 citations

Hit Papers

Methylation of GPRC5A promotes liver metastasis and docet... 2024 2026 2025 2024 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeru Tan China 9 265 186 74 73 37 26 362
Bentong Yu China 8 247 0.9× 142 0.8× 67 0.9× 44 0.6× 26 0.7× 12 318
Ramesh Elango Qatar 11 353 1.3× 277 1.5× 62 0.8× 92 1.3× 30 0.8× 19 479
Nicla Lorito Italy 9 199 0.8× 193 1.0× 87 1.2× 71 1.0× 30 0.8× 11 347
Ruyuan Yu China 13 402 1.5× 232 1.2× 91 1.2× 72 1.0× 33 0.9× 20 514
Guozhang Hu China 12 251 0.9× 150 0.8× 103 1.4× 33 0.5× 24 0.6× 16 344
Yunfei Yan China 11 289 1.1× 178 1.0× 44 0.6× 53 0.7× 30 0.8× 27 384
Shamin Rezaei Iran 6 220 0.8× 160 0.9× 49 0.7× 73 1.0× 17 0.5× 8 319
Zhaotong Wang China 7 293 1.1× 138 0.7× 51 0.7× 117 1.6× 17 0.5× 9 378
Zhouwei Zhang United States 12 209 0.8× 145 0.8× 99 1.3× 110 1.5× 33 0.9× 19 359
Ramiro J. Vicente-Blanco Spain 6 257 1.0× 175 0.9× 46 0.6× 89 1.2× 14 0.4× 6 347

Countries citing papers authored by Yeru Tan

Since Specialization
Citations

This map shows the geographic impact of Yeru Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeru Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeru Tan more than expected).

Fields of papers citing papers by Yeru Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeru Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeru Tan. The network helps show where Yeru Tan may publish in the future.

Co-authorship network of co-authors of Yeru Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Yeru Tan. A scholar is included among the top collaborators of Yeru Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeru Tan. Yeru Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Lijun, Yeru Tan, Wenjie Feng, et al.. (2025). Kinesin family member 4 a drives Cancer stem cell characteristics in breast Cancer: Insights from scRNA-Seq and experimental validation. International Journal of Biological Macromolecules. 316(Pt 1). 144308–144308. 1 indexed citations
3.
Tan, Yeru, et al.. (2025). Unveiling diagnostic biomarkers and therapeutic targets in lung adenocarcinoma using bioinformatics and experimental validation. Scientific Reports. 15(1). 22893–22893. 1 indexed citations
4.
Wu, Sixuan, Zhimin Li, Wenjie Feng, et al.. (2025). Unveiling the key mechanisms of FOLR2+ macrophage-mediated antitumor immunity in breast cancer using integrated single-cell RNA sequencing and bulk RNA sequencing. Breast Cancer Research. 27(1). 31–31. 1 indexed citations
6.
Tan, Yeru, Baohong Jiang, Wenjie Feng, et al.. (2024). Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging. 16(2). 1796–1807. 14 indexed citations
7.
Tan, Yeru, Jingping Yuan, Hailin Tang, et al.. (2024). circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Letters. 592. 216907–216907. 23 indexed citations
8.
Wu, Sixuan, et al.. (2024). Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression. Cancer Cell International. 24(1). 99–99. 4 indexed citations
9.
Ou, Xueqi, Yeru Tan, Jindong Xie, et al.. (2024). Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer. Drug Resistance Updates. 73. 101063–101063. 106 indexed citations breakdown →
10.
Feng, Wenjie, Yiling Jiang, Lijun Zeng, et al.. (2024). SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics. Cell Biology and Toxicology. 40(1). 49–49. 1 indexed citations
11.
Ou, Xueqi, Yeru Tan, Guanfeng Gao, et al.. (2023). Development and Verification of a Prognostic Stemness-Related Gene Signature in Triple-Negative Breast Cancer. Journal of Oncology. 2023. 1–13. 1 indexed citations
12.
13.
Feng, Wenjie, Hongbo Zhu, Yeru Tan, et al.. (2022). Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Frontiers in Immunology. 13. 1038225–1038225. 28 indexed citations
14.
Tan, Xinyu, Canjun Zeng, Haomiao Li, Yeru Tan, & Hongbo Zhu. (2022). Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma. Frontiers in Oncology. 12. 939994–939994. 5 indexed citations
15.
Tan, Yeru, et al.. (2021). Curative effect of hyperfractionated accelerated radiotherapy combined with EP chemotherapy regimen on limited-stage small cell lung cancer.. PubMed. 26(3). 837–843. 5 indexed citations
16.
Zhu, Hongbo, et al.. (2021). MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer. Current Cancer Drug Targets. 21(10). 860–869. 8 indexed citations
17.
Li, Yuehua, Hongbo Zhu, Xiaofei Qu, et al.. (2017). Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer. Tumor Biology. 39(6). 3726132179–3726132179. 64 indexed citations
18.
Gan, Runliang, Xiaomin Liu, Yeru Tan, et al.. (2013). Cloning and expression analysis of the gastric carcinoma-related gene, ELCOX3. Oncology Letters. 6(6). 1744–1748. 2 indexed citations
19.
Peng, Jianhong, et al.. (2000). [Pharmacological action and health protection function of Pheretima].. PubMed. 23(2). 114–7. 1 indexed citations
20.
Pallen, Catherine J., Yeru Tan, & Graeme R. Guy. (1992). Protein phosphatases in cell signalling. Current Opinion in Cell Biology. 4(6). 1000–1007. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026